The Pfizer and Moderna vaccines against SARS-CoV-2 produce strong antibody responses in people with HIV and similar antibody and cellular immune responses in people with and without HIV, two studies published in the journals AIDS and Clinical Infectious Diseases show.
Although people with HIV have been prioritised for SARS-CoV-2 vaccination in some countries, it has been unclear whether immunosuppression caused by HIV could lead to weaker vaccine responses.
Read the full story at Aidsmap.
Source : Aidsmap
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.